Cost-effectiveness of a free drug program for schizophrenia in Beijing, China

Background: Beijing municipal government launched a Free Drug Program (FDP) in 2013 to reduce the financial burden of schizophrenia patients. Objectives: To assess the cost-effectiveness of a FDP designed for schizophrenia patients in Beijing, China. Methods: In all, 2007 schizophrenia patients enro...

Full description

Saved in:
Bibliographic Details
Published in:International journal of social psychiatry 2019-02, Vol.65 (1), p.28-37
Main Authors: Yan, Fang, Yang, Yang, Huang, Qingzhi, Chen, Yun, Jia, Peiqi, Chen, Wendong, Ma, Xin
Format: Article
Language:English
Subjects:
Comorbidity
Cost analysis
Disability
GDP
Gross Domestic Product
Health care expenditures
Indirect costs
Local government
Quality adjusted life years
Quality of life
Schizophrenia
Severity
Socioeconomic factors
Socioeconomic status
Unemployment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Beijing municipal government launched a Free Drug Program (FDP) in 2013 to reduce the financial burden of schizophrenia patients. Objectives: To assess the cost-effectiveness of a FDP designed for schizophrenia patients in Beijing, China. Methods: In all, 2007 schizophrenia patients enrolled in an FDP (FDP group) and 2001 schizophrenia patients who were not enrolled (non-FDP group) were randomly selected for a cross-sectional survey in August 2015. The study sought to develop a cost-effectiveness model to assess the FDP from the societal perspective in Beijing, China. Scenario analyses explored the potential strategies to further improve the cost-effectiveness of the FDP. Results: The FDP group was associated with lower socioeconomic status and more advanced disease than the non-FDP group (unemployment rate: 48.8% vs 37.3%, p 
ISSN:0020-7640
1741-2854
DOI:10.1177/0020764018815200